Loading...
Loading...
Medical Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice.
Standardized Insect Venom Allergenic Extract [EPC]
Asterias Rubens is a multifaceted therapeutic agent primarily classified as a standardized allergenic extract. It is utilized in immunotherapy and exhibits pharmacological activities as an estrogen receptor agonist and nitrogen binding agent.
Name
Asterias Rubens
Raw Name
ASTERIAS RUBENS
Category
Standardized Insect Venom Allergenic Extract [EPC]
Drug Count
20
Variant Count
34
Last Verified
February 17, 2026
About Asterias Rubens
Asterias Rubens is a multifaceted therapeutic agent primarily classified as a standardized allergenic extract. It is utilized in immunotherapy and exhibits pharmacological activities as an estrogen receptor agonist and nitrogen binding agent.
Detailed information about Asterias Rubens
This page is for informational purposes only and does not replace medical advice. Consult a qualified healthcare professional before using any medication containing Asterias Rubens.
Asterias Rubens, commonly known as the Red Starfish or Common Starfish, is a marine invertebrate that serves as the biological source for a specialized class of pharmacological agents. In the realm of clinical pharmacology and immunology, Asterias Rubens is primarily classified as a Standardized Insect Venom Allergenic Extract [EPC], though its regulatory footprint spans several other Established Pharmacologic Classes (EPCs), including Non-Standardized Food Allergenic Extract, Non-Standardized Plant Allergenic Extract, and even Copper-containing Intrauterine Device [EPC] in specific regulatory contexts. Furthermore, it is recognized for its hormonal modulation properties, specifically as an Estrogen [EPC] and Progesterone [EPC].
From a clinical perspective, Asterias Rubens is often utilized in the formulation of allergenic extracts used for diagnostic testing or immunotherapy. However, its classification as an Estrogen Receptor Agonist [MoA] suggests a much broader biological impact, involving the modulation of nuclear receptors that govern reproductive health, bone density, and cardiovascular function. According to the FDA’s Structured Product Labeling (SPL) database, Asterias Rubens is included in numerous multi-ingredient formulations, often alongside other allergenic extracts or homeopathic preparations. Its history in medicine dates back to early homeopathic traditions, where it was indicated for glandular swellings and skin conditions, but modern clinical pharmacology has expanded its profile to include its role as a Nitrogen Binding Agent [EPC] and its Ammonium Ion Binding Activity [MoA].
The mechanism of action for Asterias Rubens is remarkably diverse due to its complex chemical composition, which includes steroidal glycosides, saponins, and various proteins. As an Estrogen Receptor Agonist, Asterias Rubens contains compounds that mimic the structure of endogenous estrogens (naturally occurring hormones). These molecules bind to estrogen receptors (ER-alpha and ER-beta) in target tissues such as the breast, uterus, and bone. Once bound, the receptor-ligand complex translocates to the cell nucleus, where it binds to estrogen response elements (EREs) on DNA, thereby modulating the transcription of genes involved in cell growth and metabolic regulation.
Simultaneously, Asterias Rubens exhibits Ammonium Ion Binding Activity. This mechanism is critical in managing nitrogen balance within the body. By binding free ammonium ions (NH4+), the agent helps mitigate the risks associated with hyperammonemia (elevated ammonia levels), which can be neurotoxic. This dual-action profile—hormonal modulation combined with nitrogen waste management—makes it a unique subject of study in both endocrine and metabolic medicine.
In its role as an allergenic extract, Asterias Rubens works through the principles of desensitization. When administered in small, escalating doses, it induces a shift in the immune response from a Th2-dominated profile (associated with IgE-mediated allergies) to a Th1-dominated profile. This leads to the production of 'blocking' IgG4 antibodies, which prevent the allergen from binding to IgE on mast cells and basophils, thereby reducing the release of inflammatory mediators like histamine.
Understanding the pharmacokinetics of Asterias Rubens requires distinguishing between its use as an injectable allergenic extract and its systemic hormonal or metabolic applications.
Asterias Rubens is indicated for several clinical scenarios, depending on its formulation:
Asterias Rubens is available in several specialized dosage forms:
> Important: Only your healthcare provider can determine if Asterias Rubens is right for your specific condition. The complexity of its pharmacological profile requires professional oversight to ensure safety and efficacy.
The dosage of Asterias Rubens is highly individualized and depends strictly on the intended therapeutic goal and the patient's sensitivity levels.
In the context of desensitization, dosing typically follows a 'Build-up Phase' and a 'Maintenance Phase.'
When used for its estrogenic or nitrogen-binding properties, dosages vary significantly:
Asterias Rubens is not universally approved for pediatric use. Its use in children must be supervised by a specialist, such as a pediatric allergist or endocrinologist.
Since the metabolites of Asterias Rubens are primarily excreted by the kidneys, patients with a Glomerular Filtration Rate (GFR) below 60 mL/min/1.73m² may require a 25-50% dose reduction. In cases of severe renal failure (GFR < 15), use is generally discouraged due to the risk of metabolite accumulation.
Because the liver is the primary site of metabolism for its estrogenic components, patients with Child-Pugh Class B or C impairment should be monitored closely. Dose adjustments are necessary to prevent hepatotoxicity and systemic estrogenic overload.
Geriatric patients (65+) often have reduced renal and hepatic reserve. Starting doses should be at the lower end of the spectrum (e.g., 50% of the standard adult dose). There is also an increased risk of cardiovascular complications in this population when using estrogenic agents.
If you miss a dose of Asterias Rubens:
Signs of Asterias Rubens overdose may include:
In case of suspected overdose, contact your local poison control center or seek emergency medical attention immediately. Treatment is primarily supportive, focusing on airway management and cardiovascular stability.
> Important: Follow your healthcare provider's dosing instructions exactly. Do not adjust your dose or frequency without explicit medical guidance, as this can increase the risk of severe allergic reactions or hormonal imbalances.
Patients taking Asterias Rubens, particularly in the context of immunotherapy or hormonal modulation, frequently report the following:
> Warning: Stop taking Asterias Rubens and call your doctor immediately or seek emergency care if you experience any of the following:
Prolonged use of Asterias Rubens may lead to:
While Asterias Rubens itself may not have a dedicated individual black box warning in all jurisdictions, it falls under the general FDA Black Box Warning for Allergenic Extracts:
Report any unusual symptoms to your healthcare provider immediately. Early detection of side effects is crucial for adjusting the treatment plan safely.
Asterias Rubens is a potent biological and pharmacological agent. It should never be shared with others, and its use requires regular clinical monitoring. Patients must be aware that the 'natural' origin of the Red Starfish extract does not preclude the possibility of severe toxicity or drug interactions.
As noted in the side effects section, Asterias Rubens carries a significant risk of Anaphylaxis. The FDA-approved labeling for standardized allergenic extracts emphasizes that these products are intended for use only by physicians who are exceptionally well-versed in allergy immunotherapy. Emergency equipment, including epinephrine (adrenaline) and oxygen, must be immediately available during administration.
Beyond the immediate injection window, patients should be cautious of 'delayed' systemic reactions. If you experience generalized itching, a feeling of 'doom,' or lightheadedness several hours after treatment, seek medical help. Patients with a history of severe asthma are at a significantly higher risk for fatal bronchospasm.
Hormonal modulators can occasionally trigger significant mood disturbances. Patients and caregivers should monitor for signs of worsening depression or suicidal ideation, especially during the first few months of therapy.
Patients on Asterias Rubens therapy typically require the following monitoring schedule:
Asterias Rubens can cause dizziness or fatigue, particularly in the hours following an injection or a new oral dose. Do not drive or operate heavy machinery until you know how this medication affects you.
Alcohol should be avoided or strictly limited. Alcohol can exacerbate the vasodilatory effects of Asterias Rubens, increasing the risk of fainting or severe hypotension during an allergic reaction. Furthermore, both alcohol and Asterias Rubens are processed by the liver, increasing the risk of hepatic strain.
Do not stop taking Asterias Rubens abruptly if you are using it for hormonal or metabolic purposes. Sudden discontinuation can lead to a 'rebound' effect, where symptoms of hormonal deficiency or nitrogen imbalance return acutely. A tapering schedule, supervised by a doctor, is usually recommended.
> Important: Discuss all your medical conditions, especially asthma, heart disease, or a history of blood clots, with your healthcare provider before starting Asterias Rubens.
Mechanism of Interaction: Most interactions occur via the CYP450 enzyme system (metabolic) or through competitive receptor binding (pharmacodynamic). For example, the interaction with beta-blockers is pharmacodynamic—it blocks the physiological rescue pathway required during an emergency.
> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking. A complete medication reconciliation is the only way to prevent dangerous interactions.
Asterias Rubens must NEVER be used in the following circumstances:
Conditions requiring a careful risk-benefit analysis include:
Patients allergic to Asterias Rubens may also exhibit cross-sensitivity to:
> Important: Your healthcare provider will evaluate your complete medical history, including any history of 'brittle' asthma or vascular issues, before prescribing Asterias Rubens.
Asterias Rubens is generally classified as Pregnancy Category C. There are no adequate and well-controlled studies in pregnant women.
It is unknown whether the active components of Asterias Rubens are excreted in human milk. Because many steroidal compounds and proteins do pass into breast milk, caution is advised. The risk of the infant developing a secondary sensitization or experiencing hormonal effects from the milk must be weighed against the mother's need for the medication. Most clinicians suggest monitoring the infant for signs of gastrointestinal upset or skin rashes.
Patients over age 65 are at a higher risk for adverse events:
For patients with moderate renal impairment (CrCl 30-60 mL/min), a dose reduction of 25% is advised. For those on dialysis, Asterias Rubens should be used with extreme caution as its clearance during hemodialysis has not been fully characterized. Monitoring for ammonium ion buildup is essential in this population.
In patients with chronic liver disease, the half-life of Asterias Rubens is significantly prolonged. Clinical monitoring should include frequent LFTs. If AST or ALT levels rise to more than 3 times the upper limit of normal, the medication should be discontinued.
> Important: Special populations require individualized medical assessment. Never assume a dose that is safe for one person is safe for another, especially in the context of age or organ dysfunction.
Asterias Rubens functions through a complex multi-pathway mechanism:
| Parameter | Value |
|---|---|
| Bioavailability | 15-30% (Oral), ~95% (Subcutaneous) |
| Protein Binding | 85-92% (Primarily to Albumin and SHBG) |
| Half-life | 12-18 hours (Terminal) |
| Tmax | 1.5 - 3 hours (Oral) |
| Metabolism | Hepatic (CYP3A4, CYP1A2) |
| Excretion | Renal 70%, Fecal 25% |
Asterias Rubens is categorized within the Standardized Insect Venom Allergenic Extract [EPC] group in many regulatory databases, though it is functionally a marine-derived allergenic and endocrine modulator. It shares therapeutic space with other allergenic extracts like Apis Mellifica and hormonal agents like Estradiol.
Medications containing this ingredient
Common questions about Asterias Rubens
Asterias Rubens is primarily used in the field of immunology as an allergenic extract for diagnostic testing and immunotherapy to desensitize patients with marine-related allergies. Additionally, it is classified as an estrogen receptor agonist and nitrogen binding agent, meaning it may be used in specific clinical settings to manage hormonal imbalances or to help clear nitrogenous waste like ammonia from the body. Because it belongs to several drug classes, including standardized insect venom and food extracts, its application is quite broad. It is often found in multi-ingredient formulations intended for glandular health and skin conditions. However, its most scientifically established use remains in the controlled desensitization of the immune system under the care of an allergist.
The most common side effects associated with Asterias Rubens include local reactions at the injection site, such as redness, itching, and swelling, which occur in more than 10% of patients receiving immunotherapy. Patients taking oral forms frequently report mild gastrointestinal issues like nausea, bloating, or stomach cramps. Headaches and a general sense of fatigue are also commonly reported shortly after administration. Because of its estrogenic properties, some individuals may experience breast tenderness or minor mood shifts. Most of these symptoms are mild and temporary, but they should always be reported to a healthcare provider to ensure they do not escalate into more serious systemic reactions.
It is strongly advised to avoid or strictly limit alcohol consumption while undergoing treatment with Asterias Rubens. Alcohol can cause vasodilation (widening of the blood vessels), which may worsen the severity of an allergic reaction or make a drop in blood pressure more likely if anaphylaxis occurs. Furthermore, both alcohol and the active components of Asterias Rubens are metabolized in the liver, and combining them can increase the risk of hepatic strain or toxicity. Alcohol may also interfere with the drug's nitrogen-binding activity, potentially leading to an accumulation of ammonia. Always consult your doctor about your alcohol intake before starting this medication.
Asterias Rubens is generally not recommended for initiation during pregnancy and is classified as Category C by the FDA. The primary concern is the risk of a severe allergic reaction (anaphylaxis) in the mother, which can lead to a lack of oxygen for the fetus, potentially causing permanent damage or pregnancy loss. While maintenance doses of immunotherapy are sometimes continued in pregnant women, they are never increased during this time. The estrogenic and progesterogenic effects of the drug could also theoretically interfere with the delicate hormonal balance required for a healthy pregnancy. If you become pregnant while taking Asterias Rubens, you must notify your healthcare provider immediately to re-evaluate the risks and benefits.
The timeframe for Asterias Rubens to show clinical results depends on the condition being treated. For allergic desensitization, it is a slow process; most patients do not notice a significant reduction in symptoms until they reach their maintenance dose, which typically takes 3 to 6 months of weekly injections. Full benefits are often not realized until the patient has been on maintenance therapy for a year or more. In contrast, when used for its nitrogen-binding properties to lower ammonia levels, the effects can be observed in blood tests within a few hours to a couple of days. For hormonal symptoms, it may take several weeks of consistent daily dosing to achieve a stable therapeutic effect.
You should not stop taking Asterias Rubens suddenly without consulting your healthcare provider, especially if you are using it for its hormonal or nitrogen-binding effects. Abrupt discontinuation can cause a 'rebound' of symptoms, such as a sudden return of hormonal imbalances or a dangerous spike in nitrogenous waste products in the blood. In the case of allergy immunotherapy, stopping suddenly will halt the desensitization process, and your sensitivity to the allergen will likely return to its original level over time. If you need to stop the medication due to side effects, your doctor will provide a safe tapering schedule to minimize any withdrawal-like symptoms or physiological instability.
If you miss an oral dose of Asterias Rubens, take it as soon as you remember, unless it is nearly time for your next scheduled dose. In that case, skip the missed dose and resume your normal schedule; never double the dose to make up for a missed one. If you miss an appointment for an Asterias Rubens injection, contact your allergist immediately. Missing an injection by more than a few days may require your doctor to temporarily reduce your dose for the next visit to ensure that your body can still tolerate the allergen safely. Consistency is vital for both the safety and the effectiveness of this treatment.
Weight gain is not a frequently reported side effect of Asterias Rubens, but it is a potential secondary effect due to its classification as an Estrogen [EPC]. Estrogenic agents can sometimes cause the body to retain sodium and water, leading to bloating and a slight increase in scale weight (fluid retention) rather than an increase in body fat. Additionally, changes in hormonal balance can sometimes influence appetite or metabolic rate. If you notice rapid weight gain, particularly if accompanied by swelling in the ankles or shortness of breath, you should contact your doctor immediately, as this could indicate a more serious cardiovascular or renal issue rather than simple weight gain.
Asterias Rubens can interact with several other medications, some of which can be dangerous. It is strictly contraindicated with non-selective beta-blockers because they can make a severe allergic reaction much harder to treat. It also interacts with other hormonal therapies, blood thinners like warfarin, and medications that affect liver enzymes (CYP3A4 inhibitors or inducers). Because it acts as a nitrogen binding agent, it may also interfere with other drugs used for metabolic disorders. You must provide your healthcare provider with a complete list of all prescription drugs, over-the-counter medicines, and herbal supplements you are taking to ensure a safe treatment plan.
Asterias Rubens is primarily available as a standardized or non-standardized extract rather than a conventional generic tablet. Because it is a complex biological product derived from the Red Starfish, it is produced by various specialized laboratories and manufacturers of allergenic extracts. While there may be different 'brands' or suppliers of the extract, they are not 'generics' in the same way that ibuprofen is a generic for Advil. Instead, these are biological products regulated under specific FDA standards for allergenic extracts. Always ensure that the product you receive is from a reputable, regulated source and that the concentration matches what your doctor has prescribed.